Humana Inc.
HUM
$249.53
-$3.82-1.51%
NYSE
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 7.80% | 10.25% | 11.31% | 10.43% | 10.64% |
| Total Other Revenue | 25.68% | 14.01% | 9.98% | 10.67% | 13.21% |
| Total Revenue | 8.45% | 10.40% | 11.26% | 10.44% | 10.73% |
| Cost of Revenue | 5.62% | 11.41% | 15.52% | 13.77% | 14.94% |
| Gross Profit | 24.29% | 4.13% | -8.57% | -5.00% | -8.13% |
| SG&A Expenses | 11.38% | 13.29% | 2.50% | -1.00% | 1.14% |
| Depreciation & Amortization | -12.44% | 3.48% | 4.48% | 10.99% | 12.37% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 6.10% | 11.59% | 13.77% | 11.93% | 13.28% |
| Operating Income | 61.11% | -331.52% | -38.49% | -15.81% | -26.41% |
| Income Before Tax | 66.46% | -46.18% | -41.53% | -28.04% | -38.01% |
| Income Tax Expenses | 61.75% | -188.00% | -39.45% | -24.66% | -30.08% |
| Earnings from Continuing Operations | 68.06% | -26.48% | -42.17% | -29.08% | -40.31% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | 0.00% | -900.00% | -- | -66.67% | 100.00% |
| Net Income | 67.88% | -28.10% | -42.31% | -29.20% | -40.19% |
| EBIT | 61.11% | -331.52% | -38.49% | -15.81% | -26.41% |
| EBITDA | 49.50% | -91.82% | -31.96% | -12.64% | -22.20% |
| EPS Basic | 68.31% | -30.23% | -40.86% | -26.77% | -38.20% |
| Normalized Basic EPS | 64.31% | -236.78% | -38.82% | -20.13% | -33.93% |
| EPS Diluted | 68.58% | -30.47% | -40.69% | -26.54% | -38.10% |
| Normalized Diluted EPS | 64.46% | -236.78% | -38.73% | -19.93% | -33.79% |
| Average Basic Shares Outstanding | -0.26% | -1.64% | -2.45% | -3.31% | -3.22% |
| Average Diluted Shares Outstanding | -0.35% | -1.64% | -2.60% | -3.55% | -3.42% |
| Dividend Per Share | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Payout Ratio | -0.41% | 0.24% | 0.70% | 0.36% | 0.82% |